Increasing evidence has also verified that CD39 and CD73 are the key regulatory molecules in tumor development, including tumor growth, metastasis, and angiogenesis, and their suppressive effects on the immune system in the TME (15). The gene discussed is NT5E; the disease is neoplasm.